CALB2 and Huntington disease: The ability of calretinin IHC to diagnose HD early and time-independently prevented repeated intestinal biopsies in our patient population and allowed us to perform one-stage TERPT in the first months of life, reducing the number of enterostomies and restoring colonic continuity early.